Mizuho Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Mizuho Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.48M	Sell	45,921 -6,841	-13%	-$439K	0.54%	58
2016 Q2	$3.88M	Buy	52,762 +7,303	+16%	+$516K	0.7%	35
2016 Q1	$2.93M	Buy	45,459 +6,247	+16%	+$394K	0.77%	28
2015 Q4	$2.7M	Buy	39,212 +1,189	+3%	+$78.6K	0.55%	45
2015 Q3	$2.25M	Buy	38,023 +2,073	+6%	+$132K	0.52%	46
2015 Q2	$2.39M	Sell	35,950 -9,509	-21%	-$627K	0.56%	43
2015 Q1	$2.93M	Buy	45,459 +4,600	+11%	+$288K	0.77%	28
2014 Q4	$2.41M	Buy	40,859 +35,449	+655%	+$2M	0.73%	35
2014 Q3	$277K	Sell	5,410 -31,414	-85%	-$1.57M	0.06%	169
2014 Q2	$1.79M	Buy	36,824 +5,471	+17%	+$270K	0.39%	88
2014 Q1	$1.63M	Buy	31,353 +1,040	+3%	+$55.3K	0.32%	95
2013 Q4	$1.61M	Sell	30,313 -12,330	-29%	-$628K	0.32%	98
2013 Q3	$1.97M	Sell	42,643 -6,630	-13%	-$291K	0.29%	127
2013 Q2	$2.2M	Buy	+49,273	New	+$2.14M	0.32%	116

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Mizuho Asset Management's BMY Position: Q3 2016 in Review

Mizuho Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q3 2016, selling an estimated $439K and leaving 45,921 shares worth $2.48M. The position accounts for 0.54% of the portfolio, ranked #58.

Mizuho Asset Management first reported a position in BMY in Q2 2013 and has held it in 14 quarters since. The position peaked at $3.88M in Q2 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Mizuho Asset Management held 45,921 shares of Bristol-Myers Squibb worth $2.48M as of Q3 2016.
Mizuho Asset Management sold 6,841 Bristol-Myers Squibb shares in Q3 2016, an estimated $439K.
Bristol-Myers Squibb made up 0.54% of Mizuho Asset Management's portfolio in Q3 2016, its #58 holding.
Mizuho Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 14 quarters since.
Mizuho Asset Management's Bristol-Myers Squibb position peaked at $3.88M in Q2 2016.
1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.